Characterization of a transgenic mouse model of chronic conditional platelet depletion

Abstract Background Platelets are widely recognized for their role in maintaining hemostasis. Recently, platelets have become appreciated for their varying roles in immunity, neuroprotection, and other physiological processes. While there are currently excellent methods to transiently deplete platel...

Full description

Bibliographic Details
Main Authors: Leah M. Wuescher, Sharmeen Nishat, Randall G. Worth
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:https://doi.org/10.1002/rth2.12255
_version_ 1797709473580580864
author Leah M. Wuescher
Sharmeen Nishat
Randall G. Worth
author_facet Leah M. Wuescher
Sharmeen Nishat
Randall G. Worth
author_sort Leah M. Wuescher
collection DOAJ
description Abstract Background Platelets are widely recognized for their role in maintaining hemostasis. Recently, platelets have become appreciated for their varying roles in immunity, neuroprotection, and other physiological processes. While there are currently excellent methods to transiently deplete platelets and models of thrombocytopenia, studying the roles of platelets in chronic processes can be challenging. Objective Phenotypic characterization of the PF4‐DTR mouse model of conditional platelet depletion compared to antibody depletion. Methods We describe the ability of the PF4‐DTR mouse to maintain chronic platelet depletion, along with examining the bleeding phenotype compared to antibody‐mediated platelet depletion. Results Systemic administration of diphtheria toxin resulted in >99% platelet depletion that can be maintained for >2 weeks. When compared to an antibody depletion model, PF4‐DTR mice showed similar phenotypes when challenged with tail bleed and saphenous vein measurements of hemostasis. Mice depleted with diphtheria toxin were also able to undergo adoptive transfer of platelets. If the frequency and amount of diphtheria toxin is reduced, mice can be maintained at >40% depletion for >28 days, showing that this model is tunable. Conclusions When compared to the gold standard of antibody‐mediated depletion, PF4‐DTR mice showed similar phenotypes and should be considered an important tool for examining the impact of thrombocytopenia over longer periods of time.
first_indexed 2024-03-12T06:37:03Z
format Article
id doaj.art-64ff99c0f4254d60a1abebd65a6b7afd
institution Directory Open Access Journal
issn 2475-0379
language English
last_indexed 2024-03-12T06:37:03Z
publishDate 2019-10-01
publisher Elsevier
record_format Article
series Research and Practice in Thrombosis and Haemostasis
spelling doaj.art-64ff99c0f4254d60a1abebd65a6b7afd2023-09-03T01:13:49ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792019-10-013470471210.1002/rth2.12255Characterization of a transgenic mouse model of chronic conditional platelet depletionLeah M. Wuescher0Sharmeen Nishat1Randall G. Worth2Department of Medical Microbiology and Immunology University of Toledo College of Medicine and Life Sciences Toledo OhioDepartment of Medical Microbiology and Immunology University of Toledo College of Medicine and Life Sciences Toledo OhioDepartment of Medical Microbiology and Immunology University of Toledo College of Medicine and Life Sciences Toledo OhioAbstract Background Platelets are widely recognized for their role in maintaining hemostasis. Recently, platelets have become appreciated for their varying roles in immunity, neuroprotection, and other physiological processes. While there are currently excellent methods to transiently deplete platelets and models of thrombocytopenia, studying the roles of platelets in chronic processes can be challenging. Objective Phenotypic characterization of the PF4‐DTR mouse model of conditional platelet depletion compared to antibody depletion. Methods We describe the ability of the PF4‐DTR mouse to maintain chronic platelet depletion, along with examining the bleeding phenotype compared to antibody‐mediated platelet depletion. Results Systemic administration of diphtheria toxin resulted in >99% platelet depletion that can be maintained for >2 weeks. When compared to an antibody depletion model, PF4‐DTR mice showed similar phenotypes when challenged with tail bleed and saphenous vein measurements of hemostasis. Mice depleted with diphtheria toxin were also able to undergo adoptive transfer of platelets. If the frequency and amount of diphtheria toxin is reduced, mice can be maintained at >40% depletion for >28 days, showing that this model is tunable. Conclusions When compared to the gold standard of antibody‐mediated depletion, PF4‐DTR mice showed similar phenotypes and should be considered an important tool for examining the impact of thrombocytopenia over longer periods of time.https://doi.org/10.1002/rth2.12255adoptive transferblood plateletsdiphtheria toxinmicethrombocytopenia
spellingShingle Leah M. Wuescher
Sharmeen Nishat
Randall G. Worth
Characterization of a transgenic mouse model of chronic conditional platelet depletion
Research and Practice in Thrombosis and Haemostasis
adoptive transfer
blood platelets
diphtheria toxin
mice
thrombocytopenia
title Characterization of a transgenic mouse model of chronic conditional platelet depletion
title_full Characterization of a transgenic mouse model of chronic conditional platelet depletion
title_fullStr Characterization of a transgenic mouse model of chronic conditional platelet depletion
title_full_unstemmed Characterization of a transgenic mouse model of chronic conditional platelet depletion
title_short Characterization of a transgenic mouse model of chronic conditional platelet depletion
title_sort characterization of a transgenic mouse model of chronic conditional platelet depletion
topic adoptive transfer
blood platelets
diphtheria toxin
mice
thrombocytopenia
url https://doi.org/10.1002/rth2.12255
work_keys_str_mv AT leahmwuescher characterizationofatransgenicmousemodelofchronicconditionalplateletdepletion
AT sharmeennishat characterizationofatransgenicmousemodelofchronicconditionalplateletdepletion
AT randallgworth characterizationofatransgenicmousemodelofchronicconditionalplateletdepletion